Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly diagnosed type 2 diabetes and early glycemic control.
CONCLUSIONS: Early and sustained HbA1c control between 6.5 and <7.0% is an important modifiable factor that helps reduce CV risk in patients with newly-diagnosed T2DM in real-world clinical practice.
PMID: 29065729 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Heart Disease | Ischemic Stroke | Research | Stroke | Study